1. Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA. Increasing burden of melanoma in the United States. J Invest Dermatol. 2009;129:1666–74.
2. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF. et al. SEER Cancer Statistics Review (CSR) 1975–2011. Bethesda: National Cancer Institute; 2014.
3. Jerant AF, Johnson JT, Sheridan CD, Caffrey TJ. Early detection and treatment of skin cancer. Am Fam Physician. 2000;62:357–68, 375–6, 381–2.
4. Balch CM, Gershenwald JE, Soong S‑J, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–206.
5. Menzies AM, Long GV, Murali R. Dabrafenib and its potential for the treatment of metastatic melanoma. Drug Des Devel Ther. 2012;6:391–405.